BRPI0407908A - método para a preparação de sais de adição de ácido de compostos básicos poliácidos - Google Patents

método para a preparação de sais de adição de ácido de compostos básicos poliácidos

Info

Publication number
BRPI0407908A
BRPI0407908A BRPI0407908-6A BRPI0407908A BRPI0407908A BR PI0407908 A BRPI0407908 A BR PI0407908A BR PI0407908 A BRPI0407908 A BR PI0407908A BR PI0407908 A BRPI0407908 A BR PI0407908A
Authority
BR
Brazil
Prior art keywords
acid addition
polyacid
preparation
addition salts
basic compounds
Prior art date
Application number
BRPI0407908-6A
Other languages
English (en)
Inventor
Kimiyuki Shibuya
Tadaaki Ohggiya
Takayuki Matsuda
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of BRPI0407908A publication Critical patent/BRPI0407908A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)

Abstract

"MéTODO PARA A PREPARAçãO DE SAIS DE ADIçãO DE áCIDO DE COMPOSTOS BáSICOS POLIáCIDOS". Um processo para a produção de um sal de adição de ácido de composto básico poliácido ou um aduzido de água deste caracterizado pelo fato de que um composto básico poliácido, tendo uma porção de basicidade mais forte do que aquela de piridina, é reagido com um sal de ácido de piridina. Este processo permite facilidade apropriada de alteração da quantidade de adição de ácido do sal de adição de ácido do composto básico poliácido para uma quantidade adequada para o composto básico poliácido.
BRPI0407908-6A 2003-02-28 2004-02-27 método para a preparação de sais de adição de ácido de compostos básicos poliácidos BRPI0407908A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003052700 2003-02-28
PCT/JP2004/002375 WO2004076441A1 (ja) 2003-02-28 2004-02-27 多酸性塩基化合物の酸付加塩の製造方法

Publications (1)

Publication Number Publication Date
BRPI0407908A true BRPI0407908A (pt) 2006-02-14

Family

ID=32923406

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0407908-6A BRPI0407908A (pt) 2003-02-28 2004-02-27 método para a preparação de sais de adição de ácido de compostos básicos poliácidos

Country Status (21)

Country Link
US (2) US7750150B2 (pt)
EP (1) EP1598346B1 (pt)
JP (2) JP4594863B2 (pt)
KR (1) KR101106127B1 (pt)
CN (2) CN1753886B (pt)
AT (1) ATE554083T1 (pt)
AU (1) AU2004215523B2 (pt)
BR (1) BRPI0407908A (pt)
CA (1) CA2516822C (pt)
DK (1) DK1598346T3 (pt)
EA (1) EA009045B1 (pt)
ES (1) ES2384517T3 (pt)
IL (1) IL170093A (pt)
IS (1) IS7978A (pt)
MX (1) MXPA05009129A (pt)
MY (1) MY140618A (pt)
NO (1) NO331272B1 (pt)
NZ (1) NZ541716A (pt)
PL (1) PL378292A1 (pt)
TW (2) TWI374136B (pt)
WO (1) WO2004076441A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI324600B (en) * 2003-07-07 2010-05-11 Kowa Co 2,4-bis (trifluoroethoxy) pyridine compound and drug containing the compound
JPWO2005020996A1 (ja) * 2003-08-29 2007-11-01 興和株式会社 リピド・リッチ・プラークの安定化方法及び破裂予防方法
TW200619204A (en) * 2004-12-10 2006-06-16 Kowa Co Method for reduction, stabilization and prevention of rupture of lipid rich plaque
AU2006285915B2 (en) * 2005-08-30 2011-02-24 Asahi Kasei Pharma Corporation Sulfonamide compound
US8415372B2 (en) * 2007-02-27 2013-04-09 Asahi Kasei Pharma Corporation Sulfonamide compound
CN101622243B (zh) * 2007-02-28 2013-12-04 旭化成制药株式会社 磺酰胺衍生物
JP5234825B2 (ja) 2007-07-02 2013-07-10 旭化成ファーマ株式会社 スルホンアミド化合物及びその結晶
WO2009068755A1 (en) * 2007-11-30 2009-06-04 Braggone Oy Novel siloxane polymer compositions
US20130035344A1 (en) * 2009-12-29 2013-02-07 Kowa Co., Ltd. Pharmaceutical composition for oral administration
US20120289517A1 (en) * 2009-12-29 2012-11-15 Kowa Co., Ltd. Solid pharmaceutical composition for oral administration
CA2798735A1 (en) * 2010-05-19 2011-11-24 Haruki Shibata Prophylactic and/or therapeutic agent for non-alcoholic steatohepatitis
US9777028B2 (en) * 2015-06-17 2017-10-03 Gilead Sciences, Inc. Co-crystals, salts and solid forms of tenofovir alafenamide
JPWO2018092765A1 (ja) * 2016-11-15 2019-10-17 学校法人同志社 経鼻投与用医薬組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112152A (en) * 1994-12-26 2000-11-21 Identa Ltd Process and test kit for cocaine detection
US6969711B2 (en) * 1997-05-26 2005-11-29 Kowa Company, Ltd. Cyclic diamine compounds and medicine containing the same
PT987254E (pt) * 1997-05-26 2005-04-29 Kowa Co Compostos de diamina ciclica, originais, e medicamentos que os contem
GB9826180D0 (en) 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
US20060165605A1 (en) * 2001-12-28 2006-07-27 Ye-Mon Chen Process to regenerate fcc spent catalyst
JP4745666B2 (ja) * 2002-12-12 2011-08-10 興和株式会社 ヒドロキシアルキル環状ジアミン化合物
TWI324600B (en) * 2003-07-07 2010-05-11 Kowa Co 2,4-bis (trifluoroethoxy) pyridine compound and drug containing the compound

Also Published As

Publication number Publication date
MXPA05009129A (es) 2005-10-20
NO20054100L (no) 2005-09-22
IL170093A (en) 2012-02-29
CN102702171A (zh) 2012-10-03
US20100234599A1 (en) 2010-09-16
EP1598346B1 (en) 2012-04-18
CN1753886B (zh) 2012-07-18
TWI374136B (en) 2012-10-11
US7750150B2 (en) 2010-07-06
TW200504052A (en) 2005-02-01
KR101106127B1 (ko) 2012-01-20
TWI355384B (en) 2012-01-01
NO20054100D0 (no) 2005-09-02
CA2516822A1 (en) 2004-09-10
CN102702171B (zh) 2014-09-10
MY140618A (en) 2009-12-31
ES2384517T3 (es) 2012-07-06
TW201202218A (en) 2012-01-16
CN1753886A (zh) 2006-03-29
JP2010235635A (ja) 2010-10-21
JP4594863B2 (ja) 2010-12-08
CA2516822C (en) 2012-09-25
KR20050105218A (ko) 2005-11-03
EA009045B1 (ru) 2007-10-26
NO331272B1 (no) 2011-11-14
AU2004215523A1 (en) 2004-09-10
IS7978A (is) 2005-08-12
WO2004076441A1 (ja) 2004-09-10
EP1598346A1 (en) 2005-11-23
US8518936B2 (en) 2013-08-27
JP5180998B2 (ja) 2013-04-10
JPWO2004076441A1 (ja) 2006-06-01
PL378292A1 (pl) 2006-03-20
AU2004215523B2 (en) 2009-07-16
ATE554083T1 (de) 2012-05-15
US20060079688A1 (en) 2006-04-13
NZ541716A (en) 2007-11-30
EA200501379A1 (ru) 2006-02-24
DK1598346T3 (da) 2012-05-29
EP1598346A4 (en) 2007-08-15

Similar Documents

Publication Publication Date Title
NO20054100D0 (no) Fremgangsmate for fremstilling av syreaddisjonssalter
DE602004024545D1 (de) Indungen
ATE497957T1 (de) Pyridinderivate als fungizide verbindungen
EA200702443A1 (ru) Замещенные гетероароилом серин-амиды
HK1167658A1 (en) Composition for the preparation of 17-vinyl- triflates as intermediates 17--
BRPI0514543A (pt) sais de metanossulfonato de abiraterona-3-ésteres e recuperação de sais de abiraterona-3-ésteres de solução em éter de terc-butila de metila
NO20071880L (no) Diagnostic Compounds
EA200970569A1 (ru) Применимые в качестве гербицидных соединений пиридопиразиновые производные
EA200700557A1 (ru) Замещенные гетероароилом серин-амиды
BRPI0516911A (pt) método para a preparação de um composto e composto de anilina
EA201070607A1 (ru) Гербицидные соединения
EA200870321A1 (ru) Способ получения 4-оксохинолинового соединения
FR2911607B1 (fr) Procede de preparation d'une solution d'un organophosphate de terre rare.
FR2890959B1 (fr) Procede de preparation d'une composition de platre.
ATE517904T1 (de) Ionische flüssigkeiten mit fluoralkyltriffluorborat-anionen
DE602006015458D1 (de) Verfahren zur herstellung eines carbonsäureamidderivats
DK1581504T3 (da) Fremgangsmåde til fremstilling af subsituterede imidazolderivater og intermediater anvendt i fremgangsmåden
TW200700370A (en) Producing method of haloalkylether compounds
RU2018123595A (ru) Способ получения хелатообразующего агента
RU2005105549A (ru) Способ получения коньюгатов гепарина
PL403471A1 (pl) Krystaliczna forma kompleksu hydrat akwa di(bis(S)-2-amino-3-(4-hydroksyfenylo)propano)miedz(II) i sposób jej wytwarzania
TH110856A (th) กรรมวิธีเชิงเคมี
UY27120A1 (es) Procedimiento para la preparación de la sal del ácido (d)-tartárico
TH85269A (pt)
RU2005108177A (ru) Способ получения фторорганических соединений, биоцидное антисептическое вещество на его основе

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08G Application fees: restoration [chapter 8.7 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]